STOCK TITAN

Revolution Medicines Warrant (RVMDW) Stock Price, News & Analysis

RVMDW NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
113 252 sessions, September 11, 2025 to September 11, 2026
Largest daily move
+130.9% close of April 13, 2026
1-year change
+3125.7% closing prices, September 11, 2025 to September 11, 2026

Company Description

Revolution Medicines Warrant (NASDAQ: RVMDW) is classified in the biological products, (no diagnostic substances) industry.

RVMDW has gained 3125.7% over the past year. The last closing price was $11.29.

For FY2025, Revolution Medicines Warrant reported revenue of $0 with net income of -$1.1B and diluted earnings per share of -$5.95.

This page collects what Stock Titan holds for RVMDW, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$11.29
+2.08%
+0.23
Last updated: September 11, 2026 at 15:50
+3125.7%
Performance 1 year

Revolution Medicines Warrant (RVMDW) closed at $11.29 on September 11, 2026. Over the past 12 months, the price has gained 3125.7%.

See what a $1,000 investment in RVMDW would be worth today

RVMDW Metrics & Rankings

Month to date
-1.5%
View ranking
YTD
+1101.2%
View ranking

Price returns through September 11, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

No recent news available for RVMDW.

SEC Filings

Revolution Medicines Warrant has filed 5 recent SEC filings, including 2 Form 4, 2 Form 144, 1 Form 8-K. The most recent filing was submitted on September 11, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all RVMDW SEC filings →

Financial Highlights

operating income reached -$1.2B, and net income was -$1.1B. Diluted earnings per share stood at -$5.95. The company generated -$897.7M in operating cash flow. With a current ratio of 7.14, the balance sheet reflects a strong liquidity position.

$0
Revenue (FY2025)
-$1.1B
Net Income (FY2025)
-$897.7M
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Revolution Medicines Warrant (RVMDW) currently stands at 836 shares, down 27.5% from the previous reporting period. Since September 2025, short interest has decreased by 97.3%.

Days to Cover History

Last 12 Months

Days to cover for Revolution Medicines Warrant (RVMDW) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 47.6% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1.9 days.

RVMDW Company Profile & Sector Positioning

Revolution Medicines Warrant (RVMDW) and is listed on the NASDAQ.

Frequently Asked Questions

What is the current stock price of Revolution Medicines Warrant (RVMDW)?

The current stock price of Revolution Medicines Warrant (RVMDW) is $11.29 as of September 11, 2026.

What is the revenue of Revolution Medicines Warrant (RVMDW) stock?

The FY2025 revenue of Revolution Medicines Warrant (RVMDW) is $0, from its most recent completed fiscal year.

What is the net income of Revolution Medicines Warrant (RVMDW)?

The FY2025 net income of Revolution Medicines Warrant (RVMDW) is -$1.1B, from its most recent completed fiscal year.

What is the earnings per share (EPS) of Revolution Medicines Warrant (RVMDW)?

The diluted earnings per share (EPS) of Revolution Medicines Warrant (RVMDW) is -$5.95 for FY2025, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of Revolution Medicines Warrant (RVMDW)?

The operating cash flow of Revolution Medicines Warrant (RVMDW) is -$897.7M. Learn about cash flow.

What is the current ratio of Revolution Medicines Warrant (RVMDW)?

The current ratio of Revolution Medicines Warrant (RVMDW) is 7.14, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of Revolution Medicines Warrant (RVMDW)?

The operating income of Revolution Medicines Warrant (RVMDW) is -$1.2B. Learn about operating income.